|
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Suppliers list
|
| Company Name: |
BOC Sciences |
| Tel: |
+1-631-485-4226 |
| Email: |
inquiry@bocsci.com |
|
| | β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Basic information |
| Product Name: | β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl | | Synonyms: | β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl;Bictegravir Metabolite M15Q: What is
Bictegravir Metabolite M15 Q: What is the CAS Number of
Bictegravir Metabolite M15;Bictegravir Impurity 9;(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid;Bikagwe metabolite M15;Ambrisentan Impurity 1-d3(Ambrisentan Racemate-d3);(2S,3S,4S,5R)-6-(((2R)-5,7-dioxo-2-propyl-8-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid;(2S,3S,4S,5R)-6-(((2R)-5,7-dioxo-2-propyl-8-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic ac | | CAS: | 2365156-60-9 | | MF: | C27H26F3N3O11 | | MW: | 625.51 | | EINECS: | | | Product Categories: | | | Mol File: | 2365156-60-9.mol | ![β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Structure](CAS/20211123/GIF/2365156-60-9.gif) |
| | β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Chemical Properties |
| Boiling point | 945.8±65.0 °C(Predicted) | | density | 1.75±0.1 g/cm3(Predicted) | | pka | 2.76±0.70(Predicted) |
| | β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Usage And Synthesis |
| | β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Preparation Products And Raw materials |
|